[Post-hoc analyses of adverse events in the retrocession sector: Toward a priori risk analysis].
- DOI
- 10.1016/j.pharma.2026.04.001
- Published
- 2026 Apr 15
- Container
- Annales pharmaceutiques francaises
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pharma.2026.04.001,
title = {[Post-hoc analyses of adverse events in the retrocession sector: Toward a priori risk analysis].},
author = {Bardel A and Chavent B and Dussart C and Salmon D and Carré E},
year = {2026},
journal = {Annales pharmaceutiques francaises},
doi = {10.1016/j.pharma.2026.04.001},
url = {https://doi.org/10.1016/j.pharma.2026.04.001}
}RIS
TY - JOUR TI - [Post-hoc analyses of adverse events in the retrocession sector: Toward a priori risk analysis]. AU - Bardel A AU - Chavent B AU - Dussart C AU - Salmon D AU - Carré E PY - 2026 JO - Annales pharmaceutiques francaises DO - 10.1016/j.pharma.2026.04.001 UR - https://doi.org/10.1016/j.pharma.2026.04.001 ER -
APA
A, B., B, C., C, D., D, S., & E, C. (2026). [Post-hoc analyses of adverse events in the retrocession sector: Toward a priori risk analysis].. Annales pharmaceutiques francaises. https://doi.org/10.1016/j.pharma.2026.04.001
Source records
- pubmed · retrieved 2026-09-27T11:24:46.175Z